Healthcare

in committee · United States · House Nov 20, 2025

HR 6166: Lowering Drug Costs for American Families Act

This bill expands Medicare's drug price negotiation program to cover 50 drugs (up from 20) and requires health insurers to apply negotiated prices to cost-sharing for beneficiaries. It establishes annual out-of-pocket cost-sharing limits for prescription drugs under group health plans and insurance coverage, with specific limits of $2,000 for self-only coverage in 2027 that will increase annually. The bill also sets specific cost-sharing limits for insulin products, requiring coverage with no deductible and cost-sharing of no more than $35 per 30-day supply or 25% of the negotiated price. These provisions affect Medicare beneficiaries, people with group health plans, and health insurers across the country. The bill applies to plan years beginning on or after January 1, 2027.

Topics ✓ HealthcareSupports HealthcareExpands Medicare drug negotiations, sets out-of-pocket limits, and caps insulin costs - directly lowering patient expenses and improving access to prescription drugs.95% confidence

Sub-Topics Insurance Medicare Prescription Drugs

Track

in committee · United States · House Nov 18, 2025

HR 6100: Health ACCESS Act

This bill regulates healthcare platforms that help patients find providers (like online appointment directories). It prohibits these platforms from steering patients toward specific providers based on payment, requiring full disclosure of financial ties between platforms and healthcare providers. Platforms must use objective criteria for listing providers, cannot offer medical services or collect patient data improperly, and must set fair, pre-agreed compensation rates. It directly affects health tech companies operating these platforms and healthcare providers using them to connect with patients.

Topics ✓ HealthcareSupports HealthcareProhibits payment-based steering, mandates financial transparency, and requires objective provider listings to improve patient access and protect rights in healthcare platform matching.92% confidence ✓ TechnologySupports TechnologyBill regulates healthcare platforms (technology services) by requiring data privacy protections, prohibiting improper data collection, and mandating disclosure of financial ties. This aligns with protecting consumer data and ensuring transparency ...95% confidence

Sub-Topics Telehealth

Track

in committee · United States · House Jul 15, 2026

HR 3514: Improving Seniors’ Timely Access to Care Act of 2025

This bill requires Medicare Advantage plans to implement electronic pre-approval systems for medical services by 2028 and meet transparency reporting standards starting in 2027. Plans must publicly report data on approval/denial rates, appeal outcomes, response times, and technology use for pre-approval requests, including details on how denials relate to clinical criteria. It establishes a 24-hour response timeframe for certain requests and mandates annual reviews of pre-approval requirements based on data and input from seniors and providers. The law directly affects Medicare Advantage plans, seniors enrolled in these plans, and healthcare providers who submit pre-approval requests. These changes aim to make the pre-approval process faster, more transparent, and more accountable for seniors seeking covered medical services.

Topics ✓ HealthcareSupports HealthcareRequires faster pre-approval timelines (24-hour response), transparency in denial reporting, and annual reviews to improve senior access to Medicare Advantage care, aligning with patient access and transparency indicators.92% confidence

Sub-Topics Long-Term Care Medicare Tags Seniors

Track

in committee · United States · House Feb 13, 2025

HR 1305: Improving Measurements for Loneliness and Isolation Act of 2025

HR 1305 establishes a federal working group under the Department of Health and Human Services to standardize how loneliness and isolation are measured across research and healthcare. The group, composed of senior health agency representatives and state officials from states with high and low mental health practitioner shortages, will develop consistent definitions and measurement tools by 2026. It aims to improve data quality for public health strategies, research, and healthcare planning, while ensuring tools can be used across different populations and settings. The working group must submit a report to Congress within one year of the bill’s enactment, and the initiative expires at the end of 2027. This affects federal health agencies, researchers, and healthcare providers who rely on standardized data to address social health challenges.

Topics ✓ HealthcareSupports HealthcareBill establishes federal working group to standardize loneliness/isolation measurement for mental health data, improving public health strategies and healthcare planning.85% confidence

Sub-Topics Mental Health Public Health

Track

in committee · United States · Senate Mar 18, 2026

S 2309: Veteran Burial Timeliness and Death Certificate Accountability Act

This bill requires VA-employed physicians or nurse practitioners to sign a veteran's death certificate within 48 hours of learning of their death (for natural causes), addressing delays that have lasted up to eight weeks. It directly affects veterans' families and survivors who face blocked burial arrangements and delayed access to benefits due to these certification delays. The bill also mandates annual VA reports to Congress on compliance, including the percentage of timely certifications and reasons for delays. Key provisions focus on setting a clear 48-hour deadline for VA providers and creating transparency through mandatory reporting. It does not override state medical certification laws or require VA staff to violate their licensing requirements.

Topics ✓ HealthcareSupports HealthcareRequires VA medical staff to timely certify veteran deaths, improving access to healthcare-related benefits and reducing administrative delays in veteran care.85% confidence ✓ VeteransSupports VeteransAddresses delays in death certificate processing for veterans, ensuring timely burial and benefits access for families, directly improving veteran service delivery.95% confidence

Sub-Topics Healthcare Workforce Memorials & Recognition Veteran Benefits Veteran Healthcare

Track

in committee · United States · Senate Nov 19, 2025

S 3209: NOPAIN for Veterans Act

S 3209, the NOPAIN for Veterans Act, requires the Department of Veterans Affairs (VA) to include non-opioid pain medications in its national formulary for veterans. The bill defines "non-opioid pain management drugs" as FDA-approved treatments for acute pain that don't use opioid receptors. The VA must add these drugs within one year of FDA approval or eligibility for payment under federal health programs, whichever comes first. This policy change directly affects veterans receiving VA pain management care by expanding access to non-opioid options, while prohibiting use of the Cost of War Toxic Exposures Fund to implement this provision.

Topics ✓ HealthcareSupports HealthcareMandates VA inclusion of non-opioid pain meds in formulary, expanding safer pain management access for veterans, directly strengthening healthcare treatment options without opioid reliance.95% confidence ✓ VeteransSupports VeteransMandates VA to include non-opioid pain meds in formulary, expanding veteran healthcare options without opioids per bill's explicit requirements.95% confidence

Sub-Topics Substance Abuse Veteran Benefits Veteran Healthcare Veteran Mental Health

Track

passed · United States · Senate Jul 21, 2026

S 1041: Affordable Prescriptions for Patients Act

This bill limits how many patents brand-name drug companies can use to block generic versions of biological drugs (biologics). It caps the number of patents a brand company can assert in lawsuits against generic manufacturers at 20, with no more than 10 being patents issued after a specified date. Courts may allow more patents only in specific cases, such as if the generic company fails to provide required information or if there are material changes to the product. The law applies to new applications submitted after enactment and aims to reduce patent-related delays for cheaper generic biologics.

Topics ✓ HealthcareSupports HealthcareBill reduces patent barriers for generic biologics, enabling lower-cost drug access and affordability - directly advancing patient access to medications per healthcare support indicators.95% confidence

Sub-Topics Prescription Drugs

Track

in committee · United States · Senate Feb 26, 2025

S 735: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

This bill increases funding and expands the scope of federal efforts to address sickle cell disease. It boosts annual funding for research and treatment programs from $4.455 million (2019-2023) to $8.205 million (2025-2029) and updates language to specifically include "prevention and treatment of complications" alongside disease treatment. The bill also modifies grant procedures to allow more flexible funding mechanisms for organizations working on sickle cell disease and related heritable blood disorders. It directly affects federal health agencies, researchers, and healthcare providers serving patients with sickle cell disease, focusing on concrete policy changes in funding and program scope.

Topics ✓ HealthcareSupports HealthcareBill increases federal funding for sickle cell disease research/treatment from $4.455M to $8.205M annually, expanding prevention and complications treatment scope.95% confidence

Track

in committee · United States · House Jan 7, 2025

HR 238: Healthy Technology Act of 2025

This bill amends the Federal Food, Drug, and Cosmetic Act to allow artificial intelligence (AI) and machine learning technologies to legally prescribe drugs under specific conditions. It requires AI systems to be both authorized by state law and approved by the FDA under sections 510(k), 513, 515, or 564. The law directly affects healthcare AI developers, providers, and patients by establishing a regulatory framework for AI-driven drug prescriptions. Key provisions define AI as a "practitioner" for prescription purposes only when meeting these two federal and state requirements. This creates a clear pathway for AI to legally prescribe drugs within existing FDA and state oversight.

Topics ✓ HealthcareSupports HealthcareEnables AI-driven drug prescriptions under FDA/state approval, expanding access to innovative healthcare delivery methods and establishing regulatory framework for AI in healthcare.95% confidence ✓ TechnologySupports TechnologyBill explicitly enables AI to legally prescribe drugs under FDA/state approval, creating a regulatory framework to advance AI in healthcare, supporting technology advancement.95% confidence

Sub-Topics Telehealth Artificial Intelligence Emerging Technology

Track

in committee · United States · Senate Sep 30, 2025

S 2943: ACE Veterans Act

This bill (S 2943, the ACE Veterans Act) requires the VA to allow veterans enrolled in its healthcare system to receive a full-year supply of prescribed contraceptive pills, patches, rings, or other approved contraceptive products instead of monthly refills. It directly affects veterans prescribed these products who are enrolled in VA care, ensuring they can access a year’s supply with a single prescription. Medical providers must inform veterans about this option, and the bill defines "contraceptive product" broadly to include FDA-approved methods for pregnancy prevention. The change aims to improve access and convenience for veterans managing contraceptive needs within VA healthcare.

Topics ✓ HealthcareSupports HealthcareExpands VA healthcare access for contraceptives by enabling year-long supplies, removing monthly refill barriers for veterans enrolled in VA care.95% confidence ✓ VeteransSupports VeteransRequires VA to provide full-year contraceptive supplies to enrolled veterans, improving healthcare access and convenience without monthly refills.95% confidence

Sub-Topics Veteran Education Veteran Healthcare Veteran Mental Health

Track